Integrating Proteomic Markers Improves Early-Onset Cancer Prediction: Insights From Sex-Specific Analysis of the UK Biobank Cohort
The incidence of early-onset cancer (malignancy diagnosed before age 50) is rising globally. Existing risk prediction models rely largely on conventional clinical variables and show limited discrimination. Metabolomics and proteomics offer new dimensions for risk prediction, but their incremental predictive value for early-onset cancer has not been systematically quantified. We aimed to develop and internally validate a multi-omics prediction model for early-onset cancer in the UK Biobank, and to assess the incremental improvement from sequentially adding lifestyle, metabolomic, and proteomic information.
Authors
- Zhilong Huang (ORCID: https://orcid.org/0009-0008-3474-3423)
Publication Details
- Journal
- Figshare
- Published
- 2026-11-21
- DOI
- https://doi.org/10.6084/m9.figshare.35082151
- Primary Topic
- Health, Environment, Cognitive Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00